{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:49:41Z","timestamp":1785919781043,"version":"3.56.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Genetic testing in amyotrophic lateral sclerosis (ALS) is increasingly recommended for all patients, but real-world implementation in middle-income countries remains heterogeneous. Brazilian motor neuron disease genetics has largely been characterized through protocol-based cohorts focused on the founder\n                      <jats:italic>VAPB<\/jats:italic>\n                      p.Pro56Ser variant (amyotrophic lateral sclerosis type 8, ALS8). The broader genetic landscape beyond ALS8 in Brazilian clinical populations has not been described in a large multiregional cohort. We aimed to characterize this profile.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed 1,911 patients with motor neuron disease followed at six SARAH Network rehabilitation hospitals across Brazil between 2007 and 2024. Genetic testing was clinically directed; ALS8 cases (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f78) were characterized separately. We assessed characteristics of genetically tested versus untested patients, the temporal evolution of testing modalities, and the diagnostic yield by gene and by Byrne family history classification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 1,833 patients without ALS8, 318 (17.3%) underwent genetic testing, with selection bias toward younger age, higher educational attainment, and positive family history of ALS or frontotemporal dementia (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). Testing expanded markedly after 2020, particularly\n                      <jats:italic>C9orf72<\/jats:italic>\n                      screening and next-generation sequencing panels. Panel\/exome sequencing identified pathogenic or likely pathogenic variants in 13 of 66 patients (19.7%), consistent with international literature for mixed familial-sporadic cohorts. Across all modalities, 30 patients without ALS8 carried pathogenic or likely pathogenic variants in six genes:\n                      <jats:italic>SOD1<\/jats:italic>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f15),\n                      <jats:italic>C9orf72<\/jats:italic>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f11; 7.0% of 157 tested), and\n                      <jats:italic>VCP, FUS, TBK1<\/jats:italic>\n                      , and\n                      <jats:italic>SETX<\/jats:italic>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f1 each).\n                      <jats:italic>ATXN2<\/jats:italic>\n                      intermediate-length CAG repeats were identified in 15 of 230 patients tested (6.5%), replicating the 6.3% previously reported in a Brazilian multicenter sample. Yield by Byrne classification followed a marked gradient (Definite: 89.7%, Probable: 24.0%, Possible: 15.4%, Sporadic: 4.9%;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). The\n                      <jats:italic>SOD1<\/jats:italic>\n                      spectrum included recurrent variants of likely Iberian\/European origin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This 18-year cohort defines a real-world genetic profile of motor neuron disease beyond ALS8, with diagnostic yield comparable to the literature and a Byrne gradient supporting universal testing. Beyond family history, socioeconomic factors appeared to shape access to testing, reinforcing the importance of equitable genetic testing for diagnostic precision, family counseling, and access to gene-targeted therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1883977","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:21:40Z","timestamp":1785918100000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic profile of motor neuron disease in a multiregional Brazilian cohort: an 18-year real-world experience in 1,911 patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Christian Marques","family":"Couto","sequence":"first","affiliation":[{"name":"Neurology Department, SARAH Network of Rehabilitation Hospitals","place":["Rio de Janeiro, Brazil"]},{"name":"Postgraduate Program in Neurology and Neurosciences, Faculty of Medicine, Fluminense Federal University (UFF)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Melo Queiroz","sequence":"additional","affiliation":[{"name":"Neurology Department, SARAH Network of Rehabilitation Hospitals","place":["Rio de Janeiro, Brazil"]},{"name":"Translational Neuroscience Graduate Program (PGNET), Federal University of Rio de Janeiro (UFRJ)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina","family":"da Cunha","sequence":"additional","affiliation":[{"name":"Neurology Department, SARAH Network of Rehabilitation Hospitals","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savana Camilla de Lima","family":"Santos","sequence":"additional","affiliation":[{"name":"Molecular Biology Laboratory, SARAH Network of Rehabilitation Hospitals","place":["Bras\u00edlia, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra De La Roque","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Molecular Biology Laboratory, SARAH Network of Rehabilitation Hospitals","place":["Bras\u00edlia, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo Jos\u00e9 Moreira","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Neurology and Neurosciences, Faculty of Medicine, Fluminense Federal University (UFF)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","article-title":"Correction: amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.irn.2024.04.007","article-title":"Recent advances in the genetics of familial and sporadic ALS","volume":"176","author":"Al-Chalabi","year":"2024","journal-title":"Int Rev Neurobiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS genetics, mechanisms, and therapeutics: where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/acn3.51895","article-title":"Evidence-based consensus guidelines for ALS genetic testing and counseling","volume":"10","author":"Roggenbuck","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40265-023-01904-6","article-title":"Tofersen: first approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1002\/acn3.52234","article-title":"Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis","volume":"11","author":"Ito","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e200201","DOI":"10.1212\/CPJ.0000000000200201","article-title":"Incorporating genetic testing into the care of patients with amyotrophic lateral sclerosis\/frontotemporal degeneration spectrum disorders","volume":"13","author":"Chambers","year":"2023","journal-title":"Neur Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1590\/1678-4685-gmb-2018-0076","article-title":"A systematic scoping review of the genetic ancestry of the Brazilian population","volume":"42","author":"Souza","year":"2019","journal-title":"Genet Mol Biol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","article-title":"The missing diversity in human genetic studies","volume":"177","author":"Sirugo","year":"2019","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"eadl3564","DOI":"10.1126\/science.adl3564","article-title":"Admixture\u2019s impact on Brazilian population evolution and health","volume":"388","author":"Nunes","year":"2025","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12687-024-00752-5","article-title":"Population molecular genetics in Brazil: from genomic databases and research to the implementation of precision medicine","volume":"16","author":"de Oliveira","year":"2025","journal-title":"J Community Genet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1086\/425287","article-title":"A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis","volume":"75","author":"Nishimura","year":"2004","journal-title":"Am J Hum Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00439-005-0031-y","article-title":"A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population","volume":"118","author":"Nishimura","year":"2005","journal-title":"Hum Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/21678421.2016.1254245","article-title":"Genetic analysis of patients with familial and sporadic amyotrophic lateral sclerosis in a Brazilian research center","volume":"18","author":"Chadi","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"227.e1","DOI":"10.1016\/j.neurobiolaging.2021.01.007","article-title":"Genetic epidemiology of familial ALS in Brazil","volume":"102","author":"Nunes Gon\u00e7alves","year":"2021","journal-title":"Neurobiol Aging"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"179.e1","DOI":"10.1016\/j.neurobiolaging.2018.01.007","article-title":"The frequency of the C9orf72 expansion in a Brazilian population","volume":"66","author":"Cintra","year":"2018","journal-title":"Neurobiol Aging"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"292.e15","DOI":"10.1016\/j.neurobiolaging.2018.04.020","article-title":"Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients","volume":"69","author":"Tavares de Andrade","year":"2018","journal-title":"Neurobiol Aging"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1080\/21678421.2024.2346824","article-title":"A homozygous p.Val120Leu (c.358G>C) SOD1 mutation led to slowly progressive amyotrophic lateral sclerosis in a Brazilian family","volume":"25","author":"Fernandes","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/21678421.2025.2597943","article-title":"Four families with slowly progressive ALS due to p.Val120Leu SOD1 variant in Northeast Brazil","volume":"27","author":"Gondim","year":"2026","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2026.2674020","article-title":"Clinical characterization and natural history of ALS8\/VAPB p.Pro56Ser: upper motor neurone signs, survival, and functional milestones in 78 patients","author":"Marques Couto","year":"2026","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/17482968.2010.545420","article-title":"Proposed criteria for familial amyotrophic lateral sclerosis","volume":"12","author":"Byrne","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Mot Neuron Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/21678421.2021.2007953","article-title":"A Brazilian multicentre study on the clinical and epidemiological profiles of 1116 patients with amyotrophic lateral sclerosis and its phenotypic variants","volume":"23","author":"Marques Couto","year":"2022","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis \u2013 frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref27","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12687-011-0072-y","article-title":"Consanguineous marriages: preconception consultation in primary health care settings","volume":"3","author":"Hamamy","year":"2012","journal-title":"J Community Genet"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1073\/pnas.0906079106","article-title":"Consanguinity, human evolution, and complex diseases","volume":"107","author":"Bittles","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"178.e1","DOI":"10.1016\/j.neurobiolaging.2016.11.010","article-title":"ATXN2 trinucleotide repeat length correlates with risk of ALS","volume":"51","author":"Sproviero","year":"2017","journal-title":"Neurobiol Aging"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/brain\/awac167","article-title":"ATXN2 intermediate expansions in amyotrophic lateral sclerosis","volume":"145","author":"Glass","year":"2022","journal-title":"Brain"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/genes13030537","article-title":"SOD-1 variants in amyotrophic lateral sclerosis: systematic re-evaluation according to ACMG-AMP guidelines","volume":"13","author":"Ruffo","year":"2022","journal-title":"Genes"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41431-021-00975-x","article-title":"SOD1 D91A variant in the southernmost tip of Europe: a heterozygous ALS patient resident on the island of Gozo","volume":"30","author":"Farrugia Wismayer","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1169689","DOI":"10.3389\/fneur.2023.1169689","article-title":"Clinical and molecular features of patients with amyotrophic lateral sclerosis and SOD1 mutations: a monocentric study","volume":"14","author":"Gagliardi","year":"2023","journal-title":"Front Neurol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2026.2652325","article-title":"Primary lateral sclerosis in Brazil: phenotypic heterogeneity, non-motor features, and prognostic markers in a 17-year multicentre cohort","author":"Marques Couto","year":"2026","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"88","author":"Zou","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e209161","DOI":"10.1212\/WNL.0000000000209161","article-title":"Disparities in genetic testing for neurologic disorders","volume":"102","author":"Baldwin","year":"2024","journal-title":"Neurology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1073\/pnas.1504447112","article-title":"Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations","volume":"112","author":"Kehdy","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00401-015-1436-x","article-title":"Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease","volume":"130","author":"Pottier","year":"2015","journal-title":"Acta Neuropathol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/humu.23161","article-title":"TBK1 mutation spectrum in an extended European patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis","volume":"38","author":"van der Zee","year":"2017","journal-title":"Hum Mutat"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/brain\/aws004","article-title":"Characterization of frontotemporal dementia and\/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72","volume":"135","author":"Boeve","year":"2012","journal-title":"Brain"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1136\/jnnp-2022-329376","article-title":"Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats","volume":"93","author":"Chio","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/practneurol-2013-000557","article-title":"Mimics and chameleons in motor neurone disease","volume":"13","author":"Turner","year":"2013","journal-title":"Pract Neurol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/21678421.2026.2615110","article-title":"The genetics of autosomal recessive ALS: a review of the common forms and their phenotypes","volume":"27","author":"Allen","year":"2026","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/ana.22534","article-title":"A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis","volume":"70","author":"Al-Saif","year":"2011","journal-title":"Ann Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1883977\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:21:42Z","timestamp":1785918102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1883977\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":47,"alternative-id":["10.3389\/fneur.2026.1883977"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1883977","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1883977"}}